Status:

COMPLETED

Green Tea Anticancer Mechanisms in Smokers

Lead Sponsor:

Philip Diaz

Conditions:

Cancer

Eligibility:

All Genders

23-40 years

Phase:

NA

Brief Summary

The purpose of this study is to determine whether green tea may lower the risk of certain cancers.

Detailed Description

Green tea contains phytochemicals, especially flavonoids. Phytochemicals are not absolutely required for normal functions, but may confer health benefits such as antioxidant actions. One can live with...

Eligibility Criteria

Inclusion

  • Healthy 23-40 year old males and non-pregnant females, who are moderately heavy smokers (1-1.75 packs/day, \> 2 years)

Exclusion

  • Habitual tea intake
  • Habitual flavonoid supplementation
  • Soy product intake over twice a week (soy is high in flavonoids).
  • Pulmonary diseases
  • Chronic or acute infection
  • Admission of heavy alcohol intake (\> 14 beers or drinks a week)
  • Body mass index (BMI) \> 30 (moderately overweight subjects will be taken)
  • Abnormal EKG
  • History of heart or other major health problems (ie arthritis, diabetes).
  • Subjects with slightly high blood pressure will be eligible for the project, but more severe hypertension (\>150/100)

Key Trial Info

Start Date :

June 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2013

Estimated Enrollment :

43 Patients enrolled

Trial Details

Trial ID

NCT01162642

Start Date

June 1 2010

End Date

August 1 2013

Last Update

April 21 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Ohio State University

Columbus, Ohio, United States, 43210